Personalised Exercise As Medicine. Optimising The Prescription To Maximise The Benefit
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
Humans have never been less physically active than in contemporary Western society. These studies will provide an evidence-basis to address the inactivity epidemic by laying the foundation for personalised and effective exercise prescriptions, to which people are more likely to adhere.
Diabetes Target Discovery And Drug Development In Mice And Primates
Funder
National Health and Medical Research Council
Funding Amount
$705,501.00
Summary
1.7 million Australians have diabetes, only ½ are diagnosed, and the incidence is increasing. Diabetes imposes high economic and social costs in Australia and globally. Diabetes is often not well managed with current therapies, and there is a strong need for new drugs to treat diabetes. This research project will search for new drug targets, to develop better medicines to treat diabetes.
Inflammatory Airway Diseases In Children: Mechanisms Underlying And Preventative Strategies
Funder
National Health and Medical Research Council
Funding Amount
$823,008.00
Summary
Professor Sly’s research concentrates on understanding why some children develop chronic lung disease and on finding ways to prevent this from happening.
Respiratory Phenotyping For New Targeted Approaches To Treat Sleep Apnoea
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
>9% of Australians have obstructive sleep apnoea (OSA). OSA has several causes. Untreated OSA is associated with major health consequences. <50% of OSA patients tolerate the main therapy, continuous positive airway pressure. New treatments are urgently required. This proposal aims to use & develop novel approaches to identify the causes of OSA on a per patient basis, improve current therapies & test if new targeted therapies can be used to treat OSA in appropriately selected patients.
Senior Research Fellowship In Lipoprotein Metabolism
Funder
National Health and Medical Research Council
Funding Amount
$804,106.00
Summary
A physiologist describing metabolic pathways and mechanisms that regulate lipoprotein metabolism in in vitro and in vivo systems. My research uses complex tracer studies and mathematical modelling to identify and quantitate pathways of lipid metabolism in normal and diseased states prior to and following lifestyle and/or pharmacological interventions. The focus of my research is on cardiovascular disease risk reduction.
Birth is one of the greatest physiological challenges that we will ever experience and so it is not surprising that it is a period of high risk of death. Despite the risk, our understanding of how infants transition from fetal to newborn life is limited. My research is focused on improving our understanding of how infants make the transition at birth so that we can reduce the risks for these most vulnerable of humans. In particular, I want to improve outcomes for infants born very premature.
Male Reproductive Health Including Prostate Cancer
Funder
National Health and Medical Research Council
Funding Amount
$727,685.00
Summary
My previous contributions to Andrology and Endocrinology of the Testis provide me with a significant breadth of expertise and a sustained record of contribution to Men’s Reproductive Health. My recent research effort has focused on Urology and prostate cancer. Through my prostate cancer research program, my overall strategy is to understand the biology of the prostate gland to enable the development of new therapies for prostate cancer, as well as for BPH (enlargement of the prostate) and prosta ....My previous contributions to Andrology and Endocrinology of the Testis provide me with a significant breadth of expertise and a sustained record of contribution to Men’s Reproductive Health. My recent research effort has focused on Urology and prostate cancer. Through my prostate cancer research program, my overall strategy is to understand the biology of the prostate gland to enable the development of new therapies for prostate cancer, as well as for BPH (enlargement of the prostate) and prostatitis (inflammation of the prostate gland).Read moreRead less